Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Equity Income: 2022-2024

Historic Equity Income for Caribou Biosciences (CRBU) over the last 2 years, with Sep 2024 value amounting to -$14,000.

  • Caribou Biosciences' Equity Income fell 250.00% to -$14,000 in Q3 2024 from the same period last year, while for Sep 2024 it was -$129,000, marking a year-over-year decrease of 126.32%. This contributed to the annual value of -$6,000 for FY2023, which is 95.49% up from last year.
  • Caribou Biosciences' Equity Income amounted to -$14,000 in Q3 2024, which was up 86.27% from -$102,000 recorded in Q2 2024.
  • Over the past 5 years, Caribou Biosciences' Equity Income peaked at $31,000 during Q3 2022, and registered a low of -$102,000 during Q2 2024.
  • Moreover, its 3-year median value for Equity Income was -$14,500 (2023), whereas its average is -$25,500.
  • Per our database at Business Quant, Caribou Biosciences' Equity Income skyrocketed by 237.50% in 2023 and then tumbled by 563.64% in 2024.
  • Quarterly analysis of 3 years shows Caribou Biosciences' Equity Income stood at -$60,000 in 2022, then skyrocketed by 85.00% to -$9,000 in 2023, then crashed by 250.00% to -$14,000 in 2024.
  • Its Equity Income was -$14,000 in Q3 2024, compared to -$102,000 in Q2 2024 and -$9,000 in Q4 2023.